In this large prospective analysis of patients on warfarin or dabigatran undergoing ablation for atrial fibrillation, major bleeding occurred in 6% of those on dabigatran and 1% of those on warfarin. Although uninterrupted warfarin is reasonably safe for ablations, dabigatran has significantly higher bleeding risks (abstract)
Dr. Scheurer is a clinical hospitalist and the Medical Director of Quality and Safety at the Medical University of South Carolina in Charleston, South Carolina, and is Assistant Professor of Medicine. She is a graduate of the University of Tennessee College of Medicine, completed her residency at Duke University, and completed her Masters in Clinical Research at the Medical University of South Carolina. She also serves as the Web Editor and Physician Advisor for the Society of Hospital Medicine.